Literature DB >> 11110698

Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway.

L S Quek1, J M Pasquet, I Hers, R Cornall, G Knight, M Barnes, M L Hibbs, A R Dunn, C A Lowell, S P Watson.   

Abstract

Activation of platelets by collagen is mediated by the complex glycoprotein VI (GPVI)/Fc receptor gamma (FcR gamma chain). In the current study, the role of 2 Src family kinases, Fyn and Lyn, in GPVI signaling has been examined using murine platelets deficient in one or both kinases. In the fyn(-/-) platelets, tyrosine phosphorylation of FcR gamma chain, phopholipase C (PLC) activity, aggregation, and secretion are reduced, though the time of onset of response is unchanged. In the lyn(-/-) platelets, there is a delay of up to 30 seconds in the onset of tyrosine phosphorylation and functional responses, followed by recovery of phosphorylation and potentiation of aggregation and alpha-granule secretion. Tyrosine phosphorylation and aggregation in response to stimulation by collagen-related peptide is further attenuated and delayed in fyn(-/-)lyn(-/-) double-mutant platelets, and potentiation is not seen. This study provides the first genetic evidence that Fyn and Lyn mediate FcR immune receptor tyrosine-based activation motif phosphorylation and PLC gamma 2 activation after the ligation of GPVI. Lyn plays an additional role in inhibiting platelet activation through an uncharacterized inhibitory pathway. (Blood. 2000;96:4246-4253)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110698

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

1.  Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.

Authors:  Gavin E Jarvis; Ben T Atkinson; Daniel C Snell; Steve P Watson
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

2.  Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy.

Authors:  Pratap Neelakantan; David Marin; Mike Laffan; John Goldman; Jane Apperley; Dragana Milojkovic
Journal:  Haematologica       Date:  2012-04-24       Impact factor: 9.941

3.  Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia.

Authors:  Yukako Ono; Takehiko Mori; Jun Kato; Akiko Yamane; Tomoharu Yajima; Yasushi Iwao; Toshifumi Hibi; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2010-09-08       Impact factor: 2.490

Review 4.  Signaling during platelet adhesion and activation.

Authors:  Zhenyu Li; M Keegan Delaney; Kelly A O'Brien; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

5.  Dok-2 adaptor protein regulates the shear-dependent adhesive function of platelet integrin αIIbβ3 in mice.

Authors:  Sascha C Hughan; Christopher M Spring; Simone M Schoenwaelder; Sharelle Sturgeon; Imala Alwis; Yuping Yuan; James D McFadyen; Erik Westein; Duncan Goddard; Akiko Ono; Yuji Yamanashi; Warwick S Nesbitt; Shaun P Jackson
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

6.  The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia.

Authors:  Aziz Nazha; Carlos G Romo; Hagop Kantarjian; Jorge Cortes
Journal:  Haematologica       Date:  2013-10       Impact factor: 9.941

7.  Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated Akt activation in platelets.

Authors:  Soochong Kim; Pierre Mangin; Carol Dangelmaier; Rivka Lillian; Shaun P Jackson; James L Daniel; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

8.  Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.

Authors:  Jun Mori; Zoltan Nagy; Giada Di Nunzio; Christopher W Smith; Mitchell J Geer; Rashid Al Ghaithi; Johanna P van Geffen; Silke Heising; Luke Boothman; Bibian M E Tullemans; Joao N Correia; Louise Tee; Marijke J E Kuijpers; Paul Harrison; Johan W M Heemskerk; Gavin E Jarvis; Alexander Tarakhovsky; Arthur Weiss; Alexandra Mazharian; Yotis A Senis
Journal:  Blood       Date:  2018-01-04       Impact factor: 22.113

9.  An important role of the SRC family kinase Lyn in stimulating platelet granule secretion.

Authors:  Zhenyu Li; Guoying Zhang; Junling Liu; Aleksandra Stojanovic; Changgeng Ruan; Clifford A Lowell; Xiaoping Du
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

10.  The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.

Authors:  Andrew C Pearce; Peter Wonerow; Stuart J Marshall; Jon Frampton; T Kent Gartner; Steve P Watson
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.